Abstract
Transition from an initial inflammatory phase to the disabling osteoproliferative phase in ankylosing spondylitis (AS) is very poorly understood. Elucidation of the mechanisms underlying this disease progression would identify new therapeutic targets and strategies.
Original language | English |
---|---|
Pages | 5-5 |
Number of pages | 1 |
Publication status | Published - 2013 |